Sinovac Biotech Ltd.

NASDAQ: SVA · Real-Time Price · USD
6.47
0.00 (0.00%)
At close: Feb 11, 2025, 6:18 AM

Sinovac Biotech Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.27B 4.28B 11.61B
Short-Term Investments
9.95B 7.03B 1.81B
Long-Term Investments
684.28M 661.44M 655.84M
Other Long-Term Assets
72.91M 2.82M 25K
Receivables
450.72M 609.49M 952.4M
Inventory
139.87M 180.72M 375.51M
Other Current Assets
5.17M 8.25M 10.9M
Total Current Assets
11.83B 12.13B 14.92B
Property-Plant & Equipment
1.03B 1.17B 1.08B
Goodwill & Intangibles
8.52M 79.51M 41.21M
Total Long-Term Assets
1.83B 1.99B 1.83B
Total Assets
13.66B 14.11B 16.75B
Account Payables
17.29M 19.82M 58.59M
Deferred Revenue
20.13M 33.08M 92.5M
Short-Term Debt
76.09M 4.65M 4.68M
Other Current Liabilities
343.48M 1.6B 1.34B
Total Current Liabilities
1.15B 1.09B 2.41B
Long-Term Debt
177.82M 11.51M 17.38M
Other Long-Term Liabilities
439K 240K 444K
Total Long-Term Liabilities
487.3M 310.27M 459.32M
Total Liabilities
1.64B 1.4B 2.87B
Total Debt
298.98M 74.67M 144.91M
Common Stock
100K 100K 100K
Retained Earnings
7.12B 7.23B 7.14B
Comprehensive Income
1.05B 1.15B 1.64B
Shareholders Equity
8.71B 8.92B 9.33B
Total Investments
10.64B 7.7B 2.46B